Trametinib is a MEK inhibitor, primarily indicated for the treatment of advanced solid tumors with specific gene mutations, such as melanoma, non-small cell lung cancer (NSCLC), etc.
What is Tunlametinib
Update: 12 Feb,2026 Source: Haiou Health Views: 102
